Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Yvonne Lundsholm in Biologically Active Agent Delivery
Introduction: Yvonne Lundsholm, an accomplished inventor based in Oxie, Sweden, is recognized for her significant contributions to the field of pharmaceutical delivery systems. Among her notable achievements, she has been awarded one patent that highlights her innovative approach to controlled delivery of biologically active agents.
Latest Patents: Yvonne's patent focuses on a method and composition for controlled delivery of biologically active agents, which is particularly beneficial in the treatment of periodontal disease. The invention details a composition that combines monoglycerides and vegetable oil. When this composition comes into contact with an aqueous liquid, it forms a reverse hexagonal liquid crystalline phase matrix that facilitates the controlled release of the active agent. This innovative method is especially effective when the liquid crystalline phase precursor composition is inserted directly into the periodontal pocket, allowing gingival fluid to trigger the in situ formation of the matrix.
Career Highlights: Yvonne Lundsholm is currently associated with A/S Dumex, where she continues to advance her research and innovation in the pharmaceutical field. Her single patent stands as a testament to her expertise and dedication to improving medical treatments through innovative delivery methods.
Collaborations: Throughout her career, Yvonne has worked alongside dedicated colleagues such as Pia Lading and Tomas Norling. This collaboration has undoubtedly contributed to the successful development of her patent and further advancements in their shared field of research.
Conclusion: Yvonne Lundsholm is a notable inventor whose work in controlled delivery of biologically active agents shows great potential for enhancing therapeutic outcomes in periodontal treatments. Her innovative spirit, combined with valuable collaborations, underscores the importance of research and development in the pharmaceutical industry. As she continues her work at A/S Dumex, her contributions will likely pave the way for future advancements in medical science.